Barclays raised the firm’s price target on Celestica (CLS) to $391 from $359 and keeps an Overweight rating on the shares. The company upped its fiscal 2026 guidance by $1B, but his is conservative and could be raised throughout the year, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLS:
- Celestica Sets Hybrid 2026 Annual Shareholders’ Meeting for May 19
- Celestica Sets Date and Format for 2026 Annual Shareholders’ Meeting
- Celestica Lifts 2026 Outlook After Strong AI-Driven Surge in 2025 Results
- Celestica raises FY26 adjusted EPS view to $8.75 from $8.20, cosnensus $8.49
- Celestica reports Q4 adjusted EPS $1.89, consensus $1.76